FDA Approves Stemedica Phase II Clinical Trial For Acute Myocardial…

Stemedica Cell Technologies, Inc., a leader in adult allogeneic stem cell manufacturing, research and development, announced today that the U.S. Food and Drug Administration (FDA) approved its...

(PRWeb October 02, 2012)

Read the full story at http://www.prweb.com/releases/Stemedica-Phase-II-trial/Infarction-Stem-Cells/prweb9967203.htm

Comments are closed.